MeSH tree: C23.550.835.900
An international collaboration of researchers, including Imperial College London and UCLA, has developed a collagen-binding interleukin 12 strategy that lets CAR-T cells treat prostate cancer in mice while curbing previously ...
Research led by Friedrich-Alexander-Universität Erlangen–Nürnberg provides evidence that teclistamab may offer therapeutic benefit for patients with severe forms of treatment-resistant autoimmune diseases.
Using medical data from sick patients while they're still at home, traveling in an ambulance and receiving care in the emergency room, researchers at Northeastern have used artificial intelligence to build a tool that predicts ...
Oct 16, 2025
0
12
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) and published simultaneously in The Lancet shows that a much lower dose than previously ...
Sep 18, 2025
0
19
From Bambino Gesù Children's Hospital in Rome comes a report that a third-generation CAR T cell therapy targeting GD2, designated GD2–CART01, induced durable remissions and long-term survival in children with high-risk metastatic, ...
A new human challenge trial under way in Melbourne aims to advance research into Strep A, accelerating efforts toward the development of a vaccine.
Sep 15, 2025
0
22
Clinical data demonstrate the combination of tarlatamab with anti-PD-L1 therapy as first-line maintenance has an acceptable safety profile and resulted in unprecedented overall survival in patients with extensive-stage small ...
Sep 8, 2025
0
37
A new diagnostic method would confirm sepsis infections earlier, cutting critical hours in the "race against time" to save patients' lives.
Aug 28, 2025
0
95
A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could transform how blood cancer treatments are tested and tailored for patients.
Jul 1, 2025
0
18
A team of doctors at Michigan Medicine have successfully treated a child in severe septic shock and multiorgan failure with their newly created therapeutic tool called the selective cytopheretic device.
Jun 26, 2025
0
19
